Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

NCT07356466 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ENROLLING_BY_INVITATION

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Gastric (Stomach) Cancer

Interventions

DRUG: Pucotenlimab Combined with Lenvatinib
DRUG: Oxaliplatin plus S-1 regimen

Sponsor

Fujian Medical University